ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 1677

$1.18M Total Retail Price of All Prescriptions

Rank: 47 out of 1677

987 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 987 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 987 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,511 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 1,176 570 S3 1 4
OMEPRAZOLE 767 525 2 6
GABAPENTIN 634 387 3 11
LEVOTHYROXINE SODIUM 561 394 4 5
FUROSEMIDE 449 333 5 8
ZOLPIDEM TARTRATE 447 204 6 15
SIMVASTATIN 437 353 7 1
PRAVASTATIN SODIUM 426 291 8 10
AMLODIPINE BESYLATE 398 324 9 2
LISINOPRIL 387 276 10 3
MELOXICAM 341 215 11 27
POTASSIUM CHLORIDE 330 243 12 14
RANITIDINE HCL 298 174 13 18
ATORVASTATIN CALCIUM 284 162 14 13
PANTOPRAZOLE SODIUM 278 146 15 46
CITALOPRAM HBR 273 153 16 22
WARFARIN SODIUM 257 186 17 24
PROMETHAZINE HCL 236 39 R 18 64
HYDROCHLOROTHIAZIDE 236 150 18 9
METFORMIN HCL 231 134 20 7
NEXIUM 230 132 21 19
LOSARTAN POTASSIUM 228 180 22 25
BENAZEPRIL HCL 215 110 23 53
SERTRALINE HCL 198 148 24 26
TRAMADOL HCL 194 95 25 16
CARVEDILOL 194 150 25 20
TRAZODONE HCL 192 108 27 37
ADVAIR DISKUS 182 88 28 54
DONEPEZIL HCL 176 164 29 30
FLUTICASONE PROPIONATE 174 117 30 29
CYMBALTA 173 105 31 58
METOPROLOL TARTRATE 167 122 32 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 163 138 33 17
DOXYCYCLINE HYCLATE 156 105 34 96
ATENOLOL 152 89 35 21
SPIRIVA 146 66 36 74
SYNTHROID 145 116 37 55
TAMSULOSIN HCL 140 103 38 34
GLIMEPIRIDE 139 88 39 33
CRESTOR 137 83 40 28
ROPINIROLE HCL 134 88 41 79
ALLOPURINOL 130 106 42 31
TRIAMTERENE-HCTZ 127 101 43 61
VENTOLIN HFA 126 48 44 89
CYCLOBENZAPRINE HCL 125 60 R 45 52
PREDNISONE 125 82 45 40
PROAIR HFA 123 45 47 50
MIRTAZAPINE 123 109 47 62
PAROXETINE HCL 123 63 47 67
NAMENDA 122 109 50 39
POLYETHYLENE GLYCOL 3350 112 79 51 76
LOSARTAN-HYDROCHLOROTHIAZIDE 110 59 52 42
OXYCODONE HCL-ACETAMINOPHEN 104 46 S2 53 115
TIZANIDINE HCL 103 34 54 108
PREMARIN 102 60 R 55 109
FLUOXETINE HCL 99 42 56 49
JANUVIA 98 51 57 70
SINGULAIR 96 56 58 97
AZITHROMYCIN 96 55 58 38
ENDOCET 96 56 S2 58 114
METOPROLOL SUCCINATE 92 82 61 23
AMITRIPTYLINE HCL 91 38 R 62 63
LANTUS 91 60 62 44
LYRICA 91 47 62 81
ENALAPRIL MALEATE 90 79 65 82
CIPROFLOXACIN HCL 90 58 65 57
ALENDRONATE SODIUM 90 90 65 43
GLYBURIDE 87 53 R 68 93
BENAZEPRIL-HYDROCHLOROTHIAZIDE 87 56 68 139
DIOVAN 84 75 70 45
LOVASTATIN 80 51 71 35
ESTRADIOL 78 0 R 72 129
DIGOXIN 76 56 73 71
LANTUS SOLOSTAR 76 43 73 132
CLOPIDOGREL 75 40 75 32
JANUMET 74 37 76 199
AMOXICILLIN 72 48 77 94
VENLAFAXINE HCL ER 70 47 78 92
PLAVIX 69 48 79 47
FLUCONAZOLE 68 19 80 127
ZETIA 67 49 81 75
MONTELUKAST SODIUM 65 36 82 174
DEXILANT 65 22 82 179
CLONIDINE HCL 65 50 82 36
HYDRALAZINE HCL 63 49 85 69
OXYCODONE HCL 63 16 S2 85 91
BUSPIRONE HCL 63 23 85 120
LEVOFLOXACIN 63 38 85 84
INSULIN SYRINGE 62 34 89 72
DILTIAZEM 24HR CD 62 58 89 156
METHADONE HCL 60 0 S2 91 168
LANSOPRAZOLE 60 48 91 147
QUETIAPINE FUMARATE 60 40 91 77
MECLIZINE HCL 60 51 91 110
COMBIVENT 59 37 95 105
BYSTOLIC 58 13 96 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 45 97 85
ONDANSETRON HCL 57 31 97 232
FAMOTIDINE 56 29 99 41
AMOX TR-POTASSIUM CLAVULANATE 56 36 99 126
BACLOFEN 56 0 99 142
CEFADROXIL 55 42 102 391
HYDROXYZINE HCL 54 20 R 103 148
TOPIRAMATE 54 13 103 181
MORPHINE SULFATE ER 54 0 S2 103 140
TRICOR 52 38 106 100
GLIPIZIDE 52 50 106 56
GLYBURIDE-METFORMIN HCL 51 30 R 108 121
AMLODIPINE BESYLATE-BENAZEPRIL 50 24 109 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.